A new NIH-funded study reveals crucial protein changes in spinal fluid that may provide the first specific biomarkers for frontotemporal dementia (FTD), paving the way for earlier diagnosis and treatment options.
A unique case study reveals a shocking mismatch between Alzheimer’s pathology and cognitive function in a woman with Down syndrome, raising questions about dementia diagnosis and treatment.
